Maxpro Ventures
Venture capitalTaipei · Seed–Late Stage · 7 people tracked
Find your way into Maxpro Ventures
624 people in our graph share verified history with the Maxpro Ventures team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Maxpro Ventures focuses on biomedical and healthcare innovation, backing companies across areas such as biologic drugs, cell therapy, small molecule drugs, and medical devices. The firm pairs seasoned biomedical scientific expertise with venture capital investment experience to identify and scale transformative healthcare companies in global markets. Beyond capital, it provides strategic guidance to accelerate portfolio companies' development and help bring breakthrough healthcare solutions to patients worldwide, aiming to advance patient outcomes while delivering strong financial returns.
Source: firm website, verified Aug 3, 2026.
Team · 7 people
from the firm's website
What they invest in
from 4 of 33 portfolio companiesBiotech ×4Healthtech ×4Deep Tech ×2AI & Machine Learning ×1Medical Devices ×1
HQs:China×1United States×1
Investments · 33 tracked
founders shown can be your intro path
Acepodia develops cell therapies for cancer treatment, leveraging proprietary immune cell engineering and tumor-targeting technology to create off-the-shelf therapeutic options for broad patient populations.
BiotechHealthtechMedical Devices
Patrick Y. Yang(Co-founder, former EVP of Juno Therapeutics, Roche and Genentech)inSonny Hsiao(Co-founder, UC Berkeley cell biologist)
AngenMed develops neoantigen-targeting cell-based cancer immunotherapies, including dendritic cell vaccines and neoantigen-specific T cell products personalized to each patient's tumor mutations.
BiotechDeep TechHealthtech
Apollomics is a biotechnology company focused on discovering and developing oncology therapies designed to combine with other treatments, using approaches that engage the immune system and target specific molecular pathways to inhibit cancer.
BiotechHealthtechFoster City, US
Peter Lin(Executive Officer)
BoardHung-Wen (Howard) Chen(Executive Officer, Director)Hung-Hsien Yen(Director)Yi-Kuei (Alex) Chen(Executive Officer, Director)Hong-Jung (Moses) Chen(Director)Hsien-Shu (Jerry) Tsai(Director)
Co-investorsPan-Lin CapitalQiming Venture Partners
GenScript Biotech is a life sciences company providing reagents, custom services, instruments, and biologics development solutions to research and pharmaceutical industries globally.
AI & Machine LearningBiotechDeep TechHealthtech
Sherry Shao(Rotating CEO)Phil Zhou(Chief Financial Officer)inRay Chen(President of GenScript Life Science Group)inKening Li(General Counsel and Chief Compliance Officer)inAylin Kosova Bilgin(Chief Marketing & Corporate Communications Officer)inAixi Bai(General Manager of Bestzyme)in
Portfolio news
latest coverage across their companiesAcepodia · rttnews.com · Sep 4, 2026
Frequently asked questions
- How many investments has Maxpro Ventures made?
- Maxpro Ventures has 33 tracked investments, including 1 dated in the last 24 months.
- What stage does Maxpro Ventures invest at?
- Maxpro Ventures invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What is Maxpro Ventures's typical check size?
- Maxpro Ventures typically writes checks of $10M – $13M.
- What sectors does Maxpro Ventures focus on?
- Maxpro Ventures focuses on Biotech, Deep Tech, Digital Health, Healthtech, Medical Devices, Retail Tech.
- Where is Maxpro Ventures located?
- Maxpro Ventures is headquartered in Taipei, TW.
Images
Similar investors
Khosla Ventures is a venture capital firm founded by Vinod Khosla.
Norwest Venture Partners is an investment firm whose growth equity team backs private, profitable, fast-growing companies, providing capital and hands-on support through its 'invited guest' approach.
New Alliance Capital is a Shanghai-based private equity and venture capital firm founded in 2008, focused on technology-driven sectors. Its backers include state-owned enterprise groups, insurance capital, fund-of-funds, government guidance funds, and listed companies.
Seventure Partners is a European venture capital firm, founded in 1997 and a subsidiary of Natixis Investment Managers, investing in digital technologies and life sciences companies with strong growth potential.
OneVentures is a later-stage venture capital firm that backs technology and healthcare companies, providing growth equity and credit alongside strategic and operational support.